Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Virginia · 2025 Regular Session · Bill

SB 1379: Research and Clinical Trial Cancer Consortium Initiative; established, report.

Enacted Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 1379 is a bill introduced in the Virginia Senate on January 13, 2025. According to its official title, it concerns: Research and Clinical Trial Cancer Consortium Initiative; established, report. Primary sponsor: Lashrecse Aird (Democratic). It lists 1 additional sponsor. Most recent recorded action (April 2, 2025): Acts of Assembly Chapter text (CHAP0630).

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Health; Research and Clinical Trial Cancer Consortium Initiative established; report. Establishes the Research and Clinical Trial Cancer Consortium Initiative for the purpose of coordinating, maximizing the efficiency of, and facilitating cancer clinical research and treatment efforts across the Commonwealth. The bill establishes the membership of the Initiative to include three nonlegislative citizen members and representatives of the following institutions relating to cancer clinical research and treatment: (i) the Massey Comprehensive Cancer Center at Virginia Commonwealth University, (ii) the University of Virginia Medical Center, (iii) the Leroy T. Canoles Jr. Cancer Research Center at the Eastern Virginia Health Sciences Center at Old Dominion University, (iv) the Fralin Biomedical Research Institute at Virginia Tech Carilion, (v) Hampton University, and (vi) the Inova Schar Cancer Institute.

Sponsors

Sponsors by party (alphabetical): Democratic 1 · Republican 1

NameRolePartyChamberDistrict
Lashrecse AirdPrimary sponsorDemocraticSenate13
David SuetterleinCo-sponsorRepublicanSenate4

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Acts of Assembly Chapter text (CHAP0630)
  2. Enacted, Chapter 630 (Effective 07/01/2025)
  3. Signed by Speaker as reenrolled
  4. Signed by President as reenrolled
  5. Reenrolled bill text (SB1379ER2)
  6. Reenrolled
  7. Governor's recommendation adopted
  8. House concurred in Governor's recommendation (96-Y 0-N)
  9. Senate concurred in Governor's recommendation (40-Y 0-N)
  10. Governor's substitute printed (SB1379S1)
  11. Governor's recommendation received by Senate
  12. Governor's Action Deadline 11:59 p.m., March 24, 2024

Showing 12 most recent of 40 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source